Canada should improve access to pharmaceuticals in post-COVID world

In Research by Michael Rae

Author:

Bacchus Barua

Drugs were approved in the U.S. 469 days earlier (on average) than in Canada.Read more about Canada should improve access to pharmaceuticals in post-COVID worldTags: access to medicinespharmaceutical innovationaccess to new drugsapproving new medicinepmprbCOVIDnew drug approval

Read More - The Fraser Institute